SCHEMBL6537749

SCHEMBL6537749

CCOC(=O)Cc1ncnc2c(NC(=O)c3c(Cl)cccc3Cl)cccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 5/20 0.45
MAPT P10636 4/20 0.45
LMNA P02545 1/20 0.45
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
HTT P42858 1/20 0.42
ALDH1A1 P00352 3/20 0.42
NLRP3 Q96P20 1/20 0.40
JAK2 O60674 2/20 0.40
JAK1 P23458 2/20 0.40
TYK2 P29597 2/20 0.40
GAA P10253 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
HPGD P15428 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6537864 0.83 POLB (0.45) POLBMAPTLMNAMEN1KMT2A
SCHEMBL6537664 0.83 POLB (0.45) POLBMAPTLMNAMEN1KMT2A
SCHEMBL6537904 0.81 RAB9A (0.48) POLBMAPTLMNAMEN1KMT2A
SCHEMBL6537389 0.81 POLB (0.43) POLBMAPTLMNAMEN1KMT2A
SCHEMBL6538068 0.80 MAPT (0.45) POLBMAPTLMNAMEN1KMT2A
SCHEMBL6537386 0.79 MAPT (0.51) POLBMAPTLMNAMEN1KMT2A
SCHEMBL6538209 0.79 MAPT (0.42) POLBMAPTLMNAMEN1KMT2A
SCHEMBL6537515 0.78 LMNA (0.41) POLBMAPTLMNAMEN1KMT2A
SCHEMBL8475500 0.78 MEN1 (0.45) POLBMAPTMEN1KMT2AHTT
SCHEMBL6538180 0.77 DGAT2 (0.44) POLBMAPTLMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed